BNR — Burning Rock Biotech Share News
0.000.00%
Last trade - 00:00- $29.09m
- -$42.25m
- CNY515.82m
- 57
- 71
- 48
- 61
REG - Burning Rock Biotech - Announces Resignation and Appointment of Directors
AnnouncementREG - Burning Rock Biotech - Published in the New England Journal of Medicine
AnnouncementREG - Burning Rock Biotech - Burning Rock Reports 1st Quarter Financial Results
AnnouncementREG - Burning Rock Biotech - BNR Schedules Q1 Earnings Release on May 30, 2023
AnnouncementREG - Burning Rock Biotech - BNR Publishes 2022 Annual Report on Form 20-F
AnnouncementREG - Burning Rock Biotech - Burning Rock Reports Q4 and Full Year 2022 Results
AnnouncementREG - Burning Rock Biotech - BNR Schedules 22Q4 and Full Year ER on March 28
AnnouncementREG - Burning Rock Biotech - An update on 2022 revenue guidance
AnnouncementREG - Burning Rock Biotech - BNR Received FDA Breakthrough Device Designation
AnnouncementREG - Burning Rock Biotech - Burning Rock Third Quarter 2022 Financial Results
AnnouncementREG - Burning Rock Biotech - Prospectus Supplement Filed with U.S. SEC
AnnouncementREG - Burning Rock Biotech - Admission to Trading on the London Stock Exchange
AnnouncementREG - Stock Exch Notice - Admission to Trading - 01/11/2022
AnnouncementREG - Burning Rock Biotech - Publication of a Prospectus
AnnouncementREG - Burning Rock Biotech - Publication of Registration Document
Announcement